What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation

Chloe Thomas, Alan Brennan, Edward Goka, Hazel Squires, Gilly Brenner, David Bagguley, Helen Buckley Woods, Michael P.T. Gillett, Joanna Leaviss, Mark Clowes,

BMJ Open · 2020 · 24 citations · 17 references

DOIFull text

Open access

Abstract

Substantial cost savings and health benefits would accrue if all individuals with conditions that increase CVD risk could be diagnosed, with detection of undiagnosed diabetes producing greatest benefits. Ensuring all conditions are managed according to NICE guidelines would further increase health benefits. Projected cost-savings could be invested in developing acceptable and cost-effective solutions for improving detection and management.

References

17